The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders
- PMID: 39581956
- DOI: 10.1007/s42000-024-00615-1
The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders
Abstract
Purpose: Variants in the GNB1 gene, which encodes for the beta-1 subunit of G proteins, have been associated with intellectual development disorder (OMIM: 616973), characterized by developmental delay, infantile hypotonia, seizures, and psychiatric problems. GNB1 variants may also cause a multisystem disorder, with symptoms such as hearing and vision impairment, gastrointestinal disorders, genitourinary abnormalities, and growth delay.
Case presentations: We present two pediatric patients with two novel GNB1 variants. The first patient is a 12-year old Caucasian European female with a history of neonatal hypotonia, feeding difficulties, and failure to thrive for the first 2 years of life. Subsequently, she developed grade 3 obesity, hyperphagia, and autoimmune thyroiditis. Whole Exome Sequencing (WES) revealed a novel likely pathogenic variant in the GNB1 gene (NM_002074.5:c.93_94del, p.Gln32AspfsTer46), which is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. The second patient is a 2-year old Roma female with severe failure to thrive during infancy, congenital hypothyroidism, and transient hyperoxaluria. No developmental delay was identified. Genetic testing excluded primary hyperoxaluria and WES revealed to be a novel likely pathogenic variant {NM_002074.5:c.183G > T (NP_002065.1:p.Met61Ile), which is predicted to have a damaging effect on the gene or gene product.
Conclusion: We present two rare pediatric cases with novel GNB1 variants which highlight the phenotypic variability associated with disrupted GNB1 expression. GNB1 may serve as a candidate gene for severe early onset obesity, hyperphagia, neurodevelopmental delay, and other metabolic and endocrine disorders.
Keywords: GNB1; Developmental delay; Intellectual disability; Obesity; Thyroid disorders.
© 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.
Conflict of interest statement
Declarations. Ethical approval: The study was in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments and it was approved by the Research Ethics Committee of the University Hospital of Patras, Greece. No animal studies were carried out by the authors for this article. Informed consent: The current research involves the participation of human subjects. To partake in the study, the parents of the patients gave their informed consent in a written format and the patient their informed assent, while participation was voluntary and anonymity was assured. Conflict of interest: The authors have no conflict of interest to disclose.
Similar articles
-
GNB1 and obesity: Evidence for a correlation between haploinsufficiency and syndromic obesity.Clin Obes. 2024 Aug;14(4):e12661. doi: 10.1111/cob.12661. Epub 2024 Apr 10. Clin Obes. 2024. PMID: 38596856
-
Case Report: A Novel GNB1 Mutation Causes Global Developmental Delay With Intellectual Disability and Behavioral Disorders.Front Neurol. 2021 Sep 27;12:735549. doi: 10.3389/fneur.2021.735549. eCollection 2021. Front Neurol. 2021. PMID: 34646230 Free PMC article.
-
Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features.Eur J Med Genet. 2020 Apr;63(4):103804. doi: 10.1016/j.ejmg.2019.103804. Epub 2019 Nov 4. Eur J Med Genet. 2020. PMID: 31698099
-
Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature.Am J Med Genet A. 2018 Nov;176(11):2259-2275. doi: 10.1002/ajmg.a.40472. Epub 2018 Sep 8. Am J Med Genet A. 2018. PMID: 30194818 Review.
-
GNB1 Encephalopathy: Clinical Case Report and Literature Review.Medicina (Kaunas). 2024 Apr 1;60(4):589. doi: 10.3390/medicina60040589. Medicina (Kaunas). 2024. PMID: 38674235 Free PMC article. Review.
References
-
- Lohmann K, Masuho I, Patil DN et al (2017) Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans. Hum Mol Genet 26:1078–1086. https://doi.org/10.1093/HMG/DDX018 - DOI - PubMed - PMC
-
- Uhlén M, Fagerberg L, Hallström BM et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347. https://doi.org/10.1126/SCIENCE.1260419
-
- Revah-Politi A, Sands TT, Colombo S et al (2021) GNB1 Encephalopathy. GeneReviews®
-
- Brett M, Lai AHM, Ting TW et al (2017) Acute lymphoblastic leukemia in a child with a de novo germline gnb1 mutation. Am J Med Genet A 173:550–552. https://doi.org/10.1002/AJMG.A.38026 - DOI - PubMed
-
- Schultz-Rogers L, Masuho I, Pinto e Vairo F et al (2020) Haploinsufficiency as a disease mechanism in GNB1-associated neurodevelopmental disorder. Mol Genet Genomic Med 8. https://doi.org/10.1002/MGG3.1477
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous